COVID-19 Research at MolES

In response to the COVID-19 pandemic, MolES faculty have pivoted their research to address the novel coronavirus, SARS-CoV-2. They are leveraging molecular engineering approaches and tools to develop improved diagnostics, targeted treatment strategies, and a better understanding of the virus. We highlight a few of these projects here.

MolES Director Pat Stayton developing targeted ‘radical cure’ for malaria

A research team led by University of Washington (UW) Distinguished Career Professor of Bioengineering and Molecular Engineering & Sciences (MolES) Institute Director Patrick Stayton has received a grant from the Bill & Melinda Gates Foundation to develop a new therapeutic for the radical cure (prevention of relapse) of malaria.

MolES research lab collaboration leads to cancer fighting therapy

Results of collaborative research from the Institute for Protein Design, Stayton Lab and Fred Hutchinson Cancer Research Center published in CELL magazine.

It's been said that absence makes the heart grow fonder, but recent research at the University of Washington Molecular Engineering and Sciences Institute may prove that close proximity is the recipe for success.

A recent cancer-fighting discovery was made possible by the group effort that combined the protein design and engineering skills of researchers working with Dr. David Baker, UW professor of biochemistry and head of the Institute for Protein Design (IPD) and the drug therapy and delivery research spearheaded by researchers working with Dr. Read More